/4540.T
4540.T Stock - Tsumura & Co.
Healthcare|Drug Manufacturers - Specialty & GenericJPX
$4157.00-0.55%
$23.00 (-0.55%) • Jan 16
73
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.73
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $4572.70
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4540.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4115.43 – $4198.57
TARGET (TP)$4780.55
STOP LOSS$3824.44
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.07
52W High$4718.00
52W Low$3306.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $181.09B | $150.84B | $140.04B | $129.55B | $130.88B |
| Gross Profit | $90.58B | $68.82B | $68.28B | $66.47B | $74.93B |
| Gross Margin | 50.0% | 45.6% | 48.8% | 51.3% | 57.3% |
| Operating Income | $40.13B | $20.02B | $20.92B | $22.38B | $19.38B |
| Net Income | $32.43B | $16.71B | $16.48B | $18.84B | $15.33B |
| Net Margin | 17.9% | 11.1% | 11.8% | 14.5% | 11.7% |
| EPS | $427.14 | $219.82 | $215.63 | $246.20 | $200.40 |
Company Overview
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4540.TBeat Rate
67%
Last 9 quarters
Avg Surprise
+11.9%
EPS vs Estimate
Beats / Misses
6/3
Last 12 quarters
Latest EPS
$109.10
Q4 2025
EPS Surprise History
Q1 24
+41.9%
$94.07vs$66.30
Q2 24
+23.9%
$7.32vs$5.91
Q3 24
+57.4%
$147.25vs$93.54
Q4 24
-11.0%
$83.26vs$93.54
Q1 25
+27.6%
$119.37vs$93.54
Q2 25
-38.0%
$77.24vs$124.55
Q3 25
-36.0%
$58.15vs$90.93
Q4 25
+20.0%
$109.10vs$90.93
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 6, 2026 | — | — | — | — |
Q4 2025 | Nov 10, 2025 | $90.93 | $109.10 | +20.0% | ✓ BEAT |
Q3 2025 | Aug 5, 2025 | $90.93 | $58.15 | -36.0% | ✗ MISS |
Q2 2025 | May 12, 2025 | $124.55 | $77.24 | -38.0% | ✗ MISS |
Q1 2025 | Feb 4, 2025 | $93.54 | $119.37 | +27.6% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $93.54 | $83.26 | -11.0% | ✗ MISS |
Q3 2024 | Aug 5, 2024 | $93.54 | $147.25 | +57.4% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $5.91 | $7.32 | +23.9% | ✓ BEAT |
Q1 2024 | Feb 6, 2024 | $66.30 | $94.07 | +41.9% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $50.54 | $61.50 | +21.7% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | — | $56.87 | — | — |
Q2 2023 | May 9, 2023 | — | $7.95 | — | — |
Q1 2023 | Feb 3, 2023 | — | $52.17 | — | — |
Q4 2022 | Nov 4, 2022 | — | $68.77 | — | — |
Q3 2022 | Aug 3, 2022 | — | $86.68 | — | — |
Q2 2022 | May 10, 2022 | — | $45.06 | — | — |
Q1 2022 | Feb 4, 2022 | — | $70.89 | — | — |
Q4 2021 | Nov 5, 2021 | — | $59.82 | — | — |
Q3 2021 | Aug 5, 2021 | — | $70.44 | — | — |
Q2 2021 | May 11, 2021 | — | $25.83 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4540.T
What is 4540.T's current stock price?
Tsumura & Co. (4540.T) is currently trading at $4157.00 per share. The stock has moved -0.55% today.
What is the analyst price target for 4540.T?
No analyst price targets are currently available for this stock.
What sector is Tsumura & Co. in?
Tsumura & Co. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the JPX exchange.
What is 4540.T's market cap?
Tsumura & Co. has a market capitalization of $309.02 billion, making it a mega-cap company.
Does 4540.T pay dividends?
No, Tsumura & Co. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector3360.T
Ship Healthcare Holdings, Inc.
$2704.50
Mkt Cap: $254.2B
4516.T
Nippon Shinyaku Co., Ltd.
$5397.00
Mkt Cap: $363.8B
4521.T
Kaken Pharmaceutical Co., Ltd.
$4090.00
Mkt Cap: $154.9B
4530.T
Hisamitsu Pharmaceutical Co., Inc.
$6300.00
Mkt Cap: $453.8B
4547.T
Kissei Pharmaceutical Co., Ltd.
$4725.00
Mkt Cap: $195.9B
4553.T
Towa Pharmaceutical Co., Ltd.
$3655.00
Mkt Cap: $179.9B
4887.T
Sawai Group Holdings Co., Ltd.
$2386.00
Mkt Cap: $275.5B
6849.T
Nihon Kohden Corporation
$1813.00
Mkt Cap: $295.7B
8086.T
Nipro Corporation
$1485.50
Mkt Cap: $242.3B
8129.T
Toho Holdings Co., Ltd.
$4581.00
Mkt Cap: $296.4B
Explore stocks similar to 4540.T for comparison